ARS Pharmaceuticals, Inc. SPRY

Set alert

3.05 USD 0.00 (+0.00%)

At closeNov 3, 2026, 4:00 PM EST

3.05 0.00 0.00%

After hours · Nov 3, 4:00 PM ET

2.92 Day range 3.11

2.91 52-week range 13.15

Held by insiders 16.21%

Held by institutions 95.47%

Float held by institutions 113.94%

Institutions 275

Top institutional holders
Holder	% held	Shares	Value	Reported
RA Capital Management, L.P.	10.94%	10,860,977	114.47M	Mar 30, 2026
Orbimed Advisors LLC.	8.35%	8,288,510	87.36M	Mar 30, 2026
Rubric Capital Management LP	8.06%	8,000,000	84.32M	Mar 30, 2026
Deerfield Management Company, L.P	7.56%	7,503,812	79.09M	Mar 30, 2026
Millennium Management Llc	6.02%	5,982,919	63.06M	Mar 30, 2026
Blackrock Inc.	5.05%	5,012,254	52.83M	Mar 30, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF	2.44%	2,418,584	25.49M	May 30, 2026
abrdn Healthcare Opportunities Fund	1.80%	1,783,628	18.80M	Mar 30, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	1.76%	1,749,763	18.44M	Mar 30, 2026
abrdn Healthcare Investors	1.56%	1,548,014	16.32M	Mar 30, 2026
iShares Trust-iShares Russell 2000 ETF	1.40%	1,393,126	14.68M	Apr 29, 2026
BARON INVESTMENT Fd.S TRT -BARON DISCOVERY Fd.	1.08%	1,074,609	11.33M	Mar 30, 2026

SPRY insiders
Insider	Relation	Latest transaction	Date	Shares held
FITZPATRICK ALEXANDER A.	Officer	Sale	Jun 11, 2026	90,910
FLYNN JAMES E	Beneficial Owner of more than 10% of a Class of Security	Sale	Jun 26, 2025	0
KARAS ERIC	Officer	Sale	Jun 11, 2026	12,176
LOWENTHAL RICHARD E	Chief Executive Officer	Sale	Aug 20, 2025	0
ORBIMED ADVISORS, L.L.C.	Unknown	Sale	Aug 25, 2024	0
SCOTT KATHLEEN D	Chief Financial Officer	Sale	Aug 20, 2025	18,292

Held by funds